Treatment of Early Nasal Polyposis With Topical Triamcinolone
NCT ID: NCT01222871
Last Updated: 2018-06-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE1/PHASE2
1 participants
INTERVENTIONAL
2010-07-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Efficacy of Topical Nasal Steroids Patients With Nasal Polyps
NCT01777906
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NCT07168148
Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis
NCT03607175
A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
NCT00788463
The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation
NCT02877485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Triamcinolone
Triamcinolone soaked nasopore dressing
Triamcinolone
Triamcinolone soaked nasopore dressing
Control Group
Saline soaked sponge
Saline soaked sponge
saline soaked sponge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triamcinolone
Triamcinolone soaked nasopore dressing
Saline soaked sponge
saline soaked sponge
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with early nasal polyposis
Exclusion Criteria
* Patients with active sinus infections
* Patients on long term steroids
* Allergy or sensitivity to steroids
* Patients with Antrochoanal polyps
* Patients who received topical steroids by bio-resorbable sponge or oral steroids
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Steward St. Elizabeth's Medical Center of Boston, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Catalano
Chief of Otolaryngology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Catalano, MD
Role: STUDY_DIRECTOR
Steward St. Elizabeth's Medical Center of Boston, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Elizabeth's Medical Center, 736 Cambridge St
Brighton, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00540
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.